In 2014, Marqus sat on an FDA panel to discuss sickle cell, its complications, and the need for available therapies to treat the disease. Four years later and Marqus is excited to fill his very first prescription of Endari (L-glutamine oral powder), the first FDA approved treatment for adults with sickle cell in nearly 20 years and the first drug ever designed specifically for SCD.
|
|
|
|